News & Events
2020
-
August 26, 2020K-115 (Ripasudil Hydrochloride Hydrate), a Rho Kinase Inhibitor, has been approved in Thailand
-
July 13, 2020K-115 (Ripasudil Hydrochloride Hydrate), a Rho Kinase Inhibitor, has been approved in Malaysia
-
March 11, 2020K-115 (Ripasudil Hydrochloride Hydrate), a Rho Kinase Inhibitor, has been approved in Singapore
-
February 19, 2020Fixed Combination Eye Drop of Ripasudil Hydrochloride Hydrate, a Rho Kinase Inhibitor, and Brimonidine Tartrate Started Phase 3 Clinical Studies in Japan[Developmental code: K-232]